000 01767 a2200541 4500
005 20250517003349.0
264 0 _c20150325
008 201503s 0 0 eng d
022 _a1465-3621
024 7 _a10.1093/jjco/hyu194
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPan, Deng
245 0 0 _aInterleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
_h[electronic resource]
260 _bJapanese journal of clinical oncology
_cFeb 2015
300 _a202-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma, Renal Cell
_xchemistry
650 0 4 _aChina
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aKidney Neoplasms
_xchemistry
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnosis
650 0 4 _aNeoplasm Staging
650 0 4 _aNephrectomy
_xmethods
650 0 4 _aPrognosis
650 0 4 _aProportional Hazards Models
650 0 4 _aReceptors, Interleukin-11
_xanalysis
650 0 4 _aRetrospective Studies
650 0 4 _aTissue Array Analysis
650 0 4 _aTreatment Outcome
700 1 _aXu, Le
700 1 _aLiu, Haiou
700 1 _aZhang, Weijuan
700 1 _aZhu, Yu
700 1 _aXu, Jiejie
700 1 _aGu, Jianxin
773 0 _tJapanese journal of clinical oncology
_gvol. 45
_gno. 2
_gp. 202-9
856 4 0 _uhttps://doi.org/10.1093/jjco/hyu194
_zAvailable from publisher's website
999 _c24376377
_d24376377